ArticleMolecular therapy. Methods & clinical development2021

Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia.

Lili Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.